| Sara Ali Mustafa, MD | |
|
3289 Woodburn Rd Ste 220, Annandale, VA 22003-7313 | |
| (703) 698-1080 | |
| Not Available |
| Full Name | Sara Ali Mustafa |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 17 Years |
| Location | 3289 Woodburn Rd Ste 220, Annandale, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710304761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101269428 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services - Pathology | 8426241647 | 34 |
| Old Dominion Pathology Associates, Llc | 6406045285 | 2 |
| Inova Health Care Services - Pathology | 8426241647 | 34 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
Cancer Research UK-funded scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.
A comprehensive account of the most important advances in rheumatology research from the past decade has been published in BioMed Central's open access journal Arthritis Research and Therapy (AR&T). This freely available collection of 38 articles written by an internationally recognized group of experts spanning more than 400 pages is an essential educational tool which provides clinicians and researchers with a detailed overview of the current status of basic, translational and clinical research in rheumatology.
Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B, according to Prof. Mark Spigelman of the Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem.
› Verified 9 days ago
| Entity Name | Inova Health Care Services - Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427369578 PECOS PAC ID: 8426241647 Enrollment ID: O20101020001195 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
Cancer Research UK-funded scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.
A comprehensive account of the most important advances in rheumatology research from the past decade has been published in BioMed Central's open access journal Arthritis Research and Therapy (AR&T). This freely available collection of 38 articles written by an internationally recognized group of experts spanning more than 400 pages is an essential educational tool which provides clinicians and researchers with a detailed overview of the current status of basic, translational and clinical research in rheumatology.
Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B, according to Prof. Mark Spigelman of the Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem.
› Verified 9 days ago
| Entity Name | Old Dominion Pathology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134449051 PECOS PAC ID: 6406045285 Enrollment ID: O20110110000421 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
Cancer Research UK-funded scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.
A comprehensive account of the most important advances in rheumatology research from the past decade has been published in BioMed Central's open access journal Arthritis Research and Therapy (AR&T). This freely available collection of 38 articles written by an internationally recognized group of experts spanning more than 400 pages is an essential educational tool which provides clinicians and researchers with a detailed overview of the current status of basic, translational and clinical research in rheumatology.
Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B, according to Prof. Mark Spigelman of the Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara Ali Mustafa, MD 3289 Woodburn Rd Ste 220, Annandale, VA 22003-7313 Ph: (703) 698-1080 | Sara Ali Mustafa, MD 3289 Woodburn Rd Ste 220, Annandale, VA 22003-7313 Ph: (703) 698-1080 |
News Archive
Researchers from the University of Pennsylvania and Johns Hopkins University have uncovered another reason why one of the most commonly activated proteins in cancer is so dangerous.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has received approximately $9.3 million in strategic financing, as previously announced on January 23, 2012.
Cancer Research UK-funded scientists are to examine whether identifying patterns in medication given to patients before they develop cancer could improve early diagnosis.
A comprehensive account of the most important advances in rheumatology research from the past decade has been published in BioMed Central's open access journal Arthritis Research and Therapy (AR&T). This freely available collection of 38 articles written by an internationally recognized group of experts spanning more than 400 pages is an essential educational tool which provides clinicians and researchers with a detailed overview of the current status of basic, translational and clinical research in rheumatology.
Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B, according to Prof. Mark Spigelman of the Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem.
› Verified 9 days ago
Bart J. Harmon, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 3800 Rose Ln, Annandale, VA 22003 Phone: 703-298-7428 | |
Dr. David Stanley Harrer, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 3299 Woodburn Rd, 210, Annandale, VA 22003 Phone: 703-207-7072 Fax: 703-207-7074 | |
Barrett Bolton Brown, MD Pathology Medicare: Medicare Enrolled Practice Location: 3289 Woodburn Road, Suite #220, Annandale, VA 22003 Phone: 703-698-1080 Fax: 703-698-1082 |